Tissue FFPE Sections, Skin

Référence CS814954

Conditionnement : 5x5um

Demander plus d'informations

Contactez votre distributeur local :


Téléphone :

Tissue FFPE Sections, Skin

Specifications
Product Data
Age 71
Appearance T
asm S08
CASE Diagnosis (from medical center path report) Malignant melanoma, metastatic
Case ID CX0000000517
Diagnosis Melanoma
Disease State Cancer
Gender Female
Lesional 0%
M (Distant metastasis) M1
Minimum Stage Grouping IV
N (Lymph node metastasis) NX
Necrosis 20%
Normal 0%
Pathology Verification notes from H&E review Tumor Stroma (Hypo/Acellular): Fibrosis; Other Features/Comments: Sample size: 20 mm x 2 mm
Race White or Caucasian
Sample Diagnosis (from Pathology Verification) Malignant melanoma, metastatic
Frozen Sample ID SX0001D308
Site of Finding Breast, left
Stability All FFPE tissue sections are stable for 1 year from date of purchase.
Storage Store FFPE tissue sections at +4°C.
T (Extent of Primary Tumor) TX
Tissue Skin
Tissue of Origin Skin
Tumor 70%
Tumor Grade Not Reported
Tumor Hypo/Acellular Stroma 10%
Tumor Hypercellular Stroma 0%
Description Tissue Sections (5x5um), FFPE; Skin; Malignant melanoma, metastatic
Write Your Own Review
You're reviewing:Tissue FFPE Sections, Skin
Your Rating
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Products

  • cDNA Clones
  • Antibodies
  • Proteins
  • Vectors
  • RNAi
  • Gene Expression
  • Assay Kits
  • Tissues
  • Others

Product Support

  • Product FAQs
  • Product Manuals
  • SDS
  • Citations

Customer Support

  • Order Support
  • Technical Support
  • International Distributors
  • cDNA Clone Match
  • Product Review

Learning Resources

  • Video and Webinar
  • Brochures & Flyers
  • Protocols
  • Ebooks
  • Scientific Papers
  • Bioinformatics Tools

About Us

  • About Us
  • Press Releases
  • Conferences
  • Customer Testimonials
  • Careers
  • Legal Notices
  • Contact Us